Cargando…
Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
Although hepatocellular carcinoma (HCC) is one of the deadliest health burdens worldwide, few drugs are available for its clinical treatment. However, in recent years, major breakthroughs have been made in the development of new drugs due to intensive fundamental research and numerous clinical trial...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130401/ https://www.ncbi.nlm.nih.gov/pubmed/34006331 http://dx.doi.org/10.1186/s13046-021-01968-w |